Regeneron Pharmaceuticals Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	69,491	70,063	67,044	82,513	67,906	58,937
Market Cap Growth	1.44%	4.50%	-18.75%	21.51%	15.22%	33.09%
Enterprise Value	55,825	64,997	61,627	75,521	63,577	56,365
PE Ratio	18.11	18.61	18.58	25.26	18.88	8.77
Forward PE	16.31	17.11	15.19	19.36	17.29	11.00
PEG Ratio	-	2.93	0.95	4.75	-	-
PS Ratio	5.69	5.69	5.50	7.33	6.50	4.27
PB Ratio	2.61	2.61	2.66	3.70	3.49	3.66
P/TBV Ratio	2.33	2.68	2.79	3.85	3.61	3.78
P/FCF Ratio	20.00	19.99	21.30	24.79	17.87	10.51
P/OCF Ratio	16.39	16.39	17.66	20.92	15.77	9.69
EV/Sales Ratio	4.53	5.28	5.05	6.70	6.08	4.08
EV/EBITDA Ratio	15.16	18.36	16.04	19.68	14.57	7.11
EV/EBIT Ratio	17.54	21.15	17.98	21.73	15.62	7.34
EV/FCF Ratio	16.06	18.55	19.58	22.69	16.73	10.05
Debt / Equity Ratio	0.09	0.09	0.09	0.10	0.12	0.14
Debt / EBITDA Ratio	0.66	0.66	0.61	0.61	0.53	0.29
Debt / FCF Ratio	0.66	0.66	0.74	0.70	0.61	0.41
Net Debt / Equity Ratio	-0.19	-0.19	-0.21	-0.31	-0.22	-0.16
Net Debt / EBITDA Ratio	-1.43	-1.43	-1.41	-1.82	-0.99	-0.32
Net Debt / FCF Ratio	-1.45	-1.45	-1.72	-2.10	-1.14	-0.46
Asset Turnover	0.37	0.37	0.40	0.42	0.45	0.75
Inventory Turnover	0.67	0.67	0.70	0.73	0.72	1.26
Quick Ratio	3.28	3.28	3.86	4.82	4.16	2.98
Current Ratio	4.13	4.13	4.73	5.69	5.06	3.56
Return on Equity (ROE)	14.87%	14.87%	15.95%	16.26%	20.94%	54.21%
Return on Assets (ROA)	7.87%	7.87%	10.40%	12.23%	15.49%	36.37%
Return on Invested Capital (ROIC)	11.50%	11.50%	16.48%	20.01%	23.65%	54.51%
Return on Capital Employed (ROCE)	10.22%	10.22%	12.57%	14.52%	19.92%	49.75%
Earnings Yield	5.52%	5.37%	5.38%	3.96%	5.30%	11.40%
FCF Yield	5.00%	5.00%	4.69%	4.03%	5.60%	9.51%
Dividend Yield	0.46%	0.46%	0.00%	0.00%	0.00%	0.00%
Payout Ratio	8.22%	8.22%	0.00%	0.00%	0.00%	0.00%
Buyback Yield / Dilution	4.09%	4.09%	2.78%	1.86%	1.28%	1.47%
Total Shareholder Return	4.55%	4.55%	2.78%	1.86%	1.28%	1.47%

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.